Polyneuropathy in type 2 diabetes mellitus [8]

Lancet

Volumn 358, Issue 9298, 2001, Pages 2086-

  Engel, W K ^a   Colover, Jack ^b  

^a GOOD SAMARITAN HOSPITAL   (United States)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN;

CLINICAL FEATURE; DIABETIC NEUROPATHY; DISEASE COURSE; HUMAN; LETTER; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE FIBER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OLIGODENDROGLIA; PERIPHERAL NERVE; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; REMISSION; SCHWANN CELL; SPINAL CORD; TISSUE LEVEL; ANIMAL; NOTE; PATHOLOGY; RABBIT; RAT; SPINAL CORD DISEASE; SWINE;

ANIMALS; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; HUMANS; MYELIN SHEATH; RABBITS; RATS; SPINAL CORD DISEASES; SWINE; IMMUNOGLOBULINS, INTRAVENOUS;

EID: 0035894609     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)07123-9     Document Type: Letter

References (5)

1. SEM Eaton ND Harris SM Rajbhandari Spinal-cord involvement in diabetic peripheral neuropathy Lancet 358 2001 35 36
2. WK Engel AF Prentice Some polyneuropathies in insulin-requiring adult-onset diabetes can benefit remarkably from anti-dysimmune treatments Neurology 43 1993 A255 A256
3. WK Engel Intravenous immunoglobulin–an often overlooked treatment–produces rapid, remarkable, sustained benefit in diabetic neuropathy complex, suggesting a dysimmune mechanism Ann Neurol 42 1997 414
4. DA Krendel DA Costigan LC Hopkins Successful treatment of neuropathies in patients with diabetes mellitus Arch Neurol 52 1995 1053 1061
5. KR Sharma J Cross R Ayyar A Martinez-Arizala WG Bradley Diabetic demyelinating polyneuropathy responsive to intravenous immunoglobulin therapy Neurology 52 suppl 2 1999 A128